Diseases Treated by Stem Cells
Stem cell therapies are reshaping how some diseases are treated, but the field is uneven. A handful of conditions have approved, evidence-based treatments, while many others remain in clinical trials. Understanding which diseases have real therapies today, which are on the horizon, and what the limitations are is essential for patients, caregivers, and anyone evaluating stem cell options.
- Diseases Treated by Stem Cells
- Blood and Immune Disorders with Approved Therapies
- Conditions with Emerging or Conditional Approval
- Autoimmune and Inflammatory Diseases
- Orthopedic and Tissue Repair Applications
- Neurological and Degenerative Conditions
- What Is Still Experimental
- What Patients Should Consider
More from this site
Keep reading the latest coverage
Blood and Immune Disorders with Approved Therapies
The most established stem cell treatments involve hematopoietic stem cells, usually from bone marrow, peripheral blood, or umbilical cord blood. These therapies are standard care for several blood cancers and genetic blood disorders.
- Leukemias and lymphomas
- Multiple myeloma
- Aplastic anemia
- Sickle cell disease
- Thalassemia major
- Severe combined immunodeficiency (SCID)
- Certain inherited metabolic disorders
In these diseases, high-dose chemotherapy or radiation clears diseased cells, and stem cell transplantation rebuilds a healthy blood and immune system. Outcomes depend heavily on disease stage, donor match, and patient age.
Conditions with Emerging or Conditional Approval
Regulatory approvals are expanding, though often with narrow indications. Some treatments are approved in specific regions or for specific patient subgroups, while others remain under conditional or accelerated approval pathways.
- Spinal cord injury — several therapies are approved or in late-stage trials in selected markets
- Stroke — stem cell approaches are being studied to limit damage and support recovery
- Heart failure — cell therapies aim to repair damaged heart muscle
- Type 1 diabetes — efforts focus on regenerating insulin-producing cells
- Parkinson's disease — trials test dopamine-producing cell replacements
- Age-related macular degeneration — retinal cell implants in early use
- Graft-versus-host disease — mesenchymal stem cell products approved in some countries
Autoimmune and Inflammatory Diseases
Stem cells, particularly mesenchymal stem cells, are being used or studied for diseases where the immune system attacks the body's own tissues.
- Crohn's disease with fistulizing complications
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Multiple sclerosis
- Type 1 diabetes
In some cases, stem cells reset or modulate the immune response rather than replace damaged tissue. Results vary, and long-term data are still accumulating.
Orthopedic and Tissue Repair Applications
Stem cell injections are used in orthopedics for joint degeneration, tendon injuries, and bone defects. These approaches often use a patient's own cells, and evidence ranges from promising to inconclusive depending on the specific condition.
- Osteoarthritis of the knee and hip
- Rotator cuff tears
- Non-healing bone fractures
- Cartilage defects
Regulatory status and quality of evidence differ widely across these uses.
Neurological and Degenerative Conditions
For diseases like Parkinson's, Alzheimer's, amyotrophic lateral sclerosis, and Huntington's, stem cell research focuses on replacing lost neurons or supporting surviving ones. No therapy is yet widely approved for these conditions, but clinical trials are active and some early results suggest potential for slowing progression or improving function.
What Is Still Experimental
Many clinics market stem cell treatments for conditions that lack rigorous evidence. Patients should distinguish between therapies backed by regulatory approval and large trials, and those offered outside clinical research with uncertain risks and benefits.
| Category | Examples | Current Status |
|---|---|---|
| Approved standard care | Blood cancers, sickle cell, SCID | Established worldwide |
| Conditionally approved | Graft-versus-host disease, some spinal cord therapies | Approved in specific regions or populations |
| Late-stage trials | Heart failure, Parkinson's, macular degeneration | Potential approval within years |
| Early research | Alzheimer's, ALS, Huntington's | No approved therapy yet |
| Clinic-provided, limited evidence | Orthopedic injections, autism, anti-aging | Regulatory concern in many countries |
What Patients Should Consider
When evaluating stem cell treatments, focus on the disease, the type of stem cell used, the stage of research, and the regulatory oversight. Treatments with strong evidence carry transparent risks, clear endpoints, and published trial data. Those with weak evidence often rely on anecdotal reports and lack independent verification. Consulting a specialist familiar with the specific disease and its approved therapies remains the most reliable first step.